Summary
Purpose
Comparison of the effect of different therapeutic modalities on survival time of patients with glioblastoma multiforme operated on during the last decade (1980–1990).
Patients and methods
The records of 157 consecutive patients with the histological diagnosis of glioblastoma multiforme were analysed for survival with respect to age of patients, extent of surgery, influence of re-operation and adjuvant postoperative treatment. The latter included fractionated radiotherapy, chemotherapy (BCNU, CCNU with Vincristine) and photodynamic therapy (PDT).
Results
Analysis of variance showed a significant effect for survival after macroscopically radical surgery (p=0.005), postoperative radiotherapy (p< 0.001), chemotherapy (p< 0.01). Low age (p< 0.05) and a postoperative Karnofsky performance score (KPS) ⩾60 (p< 0.001) had a positive influence; the site of tumour and pre-operative presence of seizures had no significant influence (p > 0.1) on survival time.
Conclusion
We conclude that the current adequate management of glioblastoma multiforme should include surgical resection followed by adjuvant treatment such as radiotherapy and chemotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chandler KL, Prados MD, Malec M,et al (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32: 716–720
Chang CH, Horton J, Schoenfeld D,et al (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52: 997–1007
Cohadon F (1990) Indications for surgery in the management of gliomas. In: Symon L,et al (eds) Advances and technical standards in neurosurgery, vol 17. Springer, Wien New York, pp 189–234
Dirks P, Bernstein M, Muller PJ, Tucker WS (1993) The value of reoperation for recurrent glioblastomas. Can J Surg 36: 271–275
Edwards ED, Stupperich TK, Welsh DM (1991) Hyperthermia treatment for malignant brain tumors: nursing management during therapy. J Neurosci Nurs 23: 34–38
Gately MK, Glaser M, Mc Carron RM (1982) Mechanisms by which human gliomas may escape cellular immune attack. Acta Neurochir 64: 175–197
Harsh GR, Levin VA, Gutin PH,et al (1987) Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21: 615–621
Höllerhage HG, Zumkeller M, Becker M, Dietz H (1991) Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir 113: 31–37
Huber A, Beran H, Becherer A,et al (1993) Supratentorielle Gliome: Analyse klinischer und zeitlicher Parameter in 163 Fällen. Neurochirurgia 36: 189–193
Imperato JP, Paleologos NA, Vick NA (1990) Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28: 818–822
Kaye AH, Morstyn G, Apuzzo ML (1988) Photoradiation therapy and its potential in the management of neurological tumours. J Neurosurg 69: 1–14
Kernohan JW, Mabon RF, Sieven HJ,et al (1949) A simplified classification of gliomas. Proc Staff Meet Mayo Clin 24: 71–74
Kofler A, Fritsch E, Maier H,et al (1990) Intraoperative Bestrahlung von Hirngliomen. Wien Klin Wschr 102: 528–531
Kornblith PL, Walker M (1988) Chemotherapy for malignant gliomas (review article). J Neurosurg 68: 1–17
Kornblith PL, William CW, Bardley MK (1993) The future therapy for glioblastoma. Surg Neurol 39: 538–543
Kostron H, Plangger C, Fritsch E, Maier H (1990) Photodynamic treatment of malignant brain tumors. Wien Klin Wschr 102: 531–535
Kreth FW, Warnke PC, Scheremet R,et al (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762–766
Levin VA, Silver P, Hannigan J,et al (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas. NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321–324
Loew F, Papavero L (1988) The intraarterial route of drug delivery in the chemotherapy of malignant brain tumours. In: Symon L,et al (eds) Advances and technical standards in neurosurgery, vol 16. Springer, Wien New York, pp 51–79
Martinez R, Vaquero J, Ramiro J,et al (1989) Intratumoural and intraventricular lymphoblastoid alpha interferon for treatment of glioblastoma multiforme. Acta Neurochir (Wien) 100: 46–49
Naganuma H, Kimurat R, Sasaki A,et al (1989) Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells (Case report). Acta Neurochir (Wien) 99: 157–160
Papavero L, Loew F, Jaschke H (1987) Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Acta Neurochir (Wien) 85: 128–137
Simpson JR, Horton J, Scott C,et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26: 239–244
Sneed PK, Gutin PH, Prados MD,et al (1992) Brachytherapy of brain tumors. Stereotact Funct Neurosurg 59: 157–165
Vaquero J, Martinez R, Salazar FG,et al (1991) Immunotherapy of glioblastoma with intratumoural administration of autologous lymphocytes and human lymphoblastoid interferon. A further clinical study. Acta Neurochir (Wien) 109: 42–45
Walker MD, Alexander E jr, Hunt WE,et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343
Yoshida J, Kajita T, Wakabayashi T, Sugita K (1994) Long-term follow-up results of patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir (Wien) 127: 55–59
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Obwegeser, A., Ortler, M., Seiwald, M. et al. Therapy of glioblastoma multiforme: A cumulative experience of 10 years. Acta neurochir 137, 29–33 (1995). https://doi.org/10.1007/BF02188776
Issue Date:
DOI: https://doi.org/10.1007/BF02188776